Pharma Management Consulting Denmark ApS

CVR 44364182 · Private limited company (ApS) · Active · Low risk

Pharma Management Consulting Denmark ApS is a Private limited company (ApS), founded on , based in Sorø. The company is registered in the industry rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. Our model estimates a bankruptcy risk of 0.2% over the next 12 months, which is 0.1 times the average for Danish companies. 2 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 243k and a net result of DKK 196k. CEO: David Jung Thelander Grønbæk.

Bankruptcy risk for Pharma Management Consulting Denmark ApS

0.2%
probability of bankruptcy within 12 months
Low risk

0.1 × the average (1.41%) · higher risk than 44% of active Danish companies

Lowest riskHighest risk

Increases the risk

Published annual reports2 · bankruptcy rate 16.7%1.9×
Time at current address0.5–1 yrs · bankruptcy rate 16.5%1.9×
Age (years)3–5 yrs · bankruptcy rate 13.3%1.5×
Auditor's statementNo assurance · bankruptcy rate 13.2%1.5×
Moves in the last 2 years1 · bankruptcy rate 12.7%1.4×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
Time since new CEO2–5 yrs · bankruptcy rate 10.8%1.2×
Audit opted outYes · bankruptcy rate 10.4%1.2×

Reduces the risk

Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Current ratio200%–500% · bankruptcy rate 3.4%0.39×
Gross profit growth-10%–0% · bankruptcy rate 4.3%0.49×
Equity ratio40%–60% · bankruptcy rate 4.6%0.52×
Return on assets15%+ · bankruptcy rate 5.1%0.58×
Negative equityNo · bankruptcy rate 5.1%0.58×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Loss for the yearNo · bankruptcy rate 5.3%0.60×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
44364182
Status
Active
Company type
Private limited company (ApS)
Founded
(3 years)
Address
c/o Stationen CO., Stationspladsen 2C
4180 Sorø
Municipality
Sorø
Industry
Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik (711220)
Bankruptcies in the industry: Rådgivende ingeniørvirksomhed inden for byggeri og anlægsarbejder
Share capital
DKK 40k
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 2
Missing annual reportNo
Negative equityNo
Equity ratio53.6%
Current ratio215%
Moves (last 2 years)1
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address12
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK 1.3mDKK 1.4m
Net profitDKK 196kDKK 237k
EquityDKK 243kDKK 277k
Total assetsDKK 454kDKK 523k
CashDKK 270kDKK 193k
Short-term debtDKK 211kDKK 246k
Tax owedDKK 60kDKK 76k
Avg. employees11

Latest annual report: Reporting class B · auditor's statement: No assurance.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025141
11 Oct 2023 – 31 Dec 2024104

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEODavid Jung Thelander GrønbækCurrent
Owner (100%)North Star Business Holding ApSCurrent
FounderNorth Star Business Holding ApSCurrent

The CEOs' other companies

David Jung Thelander Grønbæk – 4 other companies

Address history (1 moves)

c/o Stationen CO., Stationspladsen 2C, 4180 Sorø
Maglebjergvej 6, st., 2800 Kongens Lyngby

Other companies at the same address

Similar companies in Sorø

Questions and answers about Pharma Management Consulting Denmark ApS

Has Pharma Management Consulting Denmark ApS gone bankrupt?

No, Pharma Management Consulting Denmark ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Pharma Management Consulting Denmark ApS?

Our model estimates a bankruptcy risk of 0.2% over the next 12 months (low risk), which is 0.1 times the average for Danish companies.

Who is the CEO of Pharma Management Consulting Denmark ApS?

David Jung Thelander Grønbæk is the CEO of Pharma Management Consulting Denmark ApS.

When was Pharma Management Consulting Denmark ApS founded?

Pharma Management Consulting Denmark ApS was founded on 11 October 2023.

What is the equity of Pharma Management Consulting Denmark ApS?

Equity was DKK 243k according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.